20090203
 Panel Backs Clot Drug   By Jennifer Corbett Dooren, The Wall Street Journal,  Feb 4, 2009  A Food and Drug Administration panel Tuesday unanimously recommended approval of prasugrel, an anticlotting drug being developed by Eli Lilly & Co. and Daiichi Sankyo Co., with warnings about bleeding risks.   
